144 related articles for article (PubMed ID: 38478181)
1. Role of serum calprotectin in identifying familial Mediterranean fever attacks.
Polat MG; Omma A; Gokcen N; Kilinckaya MF; Ozkan Karaahmetoglu S
Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38478181
[TBL] [Abstract][Full Text] [Related]
2. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients?
Asan G; Derin ME; Doğan HO; Bayram M; Şahin M; Şahin A
J Korean Med Sci; 2020 Mar; 35(10):e63. PubMed ID: 32174062
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of S100A12 protein levels in children with familial Mediterranean fever.
Türkmenoğlu Y; Güney E; Bezen D; İrdem A; Ertürk B; Dursun H
Turk J Med Sci; 2021 Jun; 51(3):1396-1405. PubMed ID: 33576586
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Serum Resistin and Plasma Calprotectin Levels as Biomarkers of Inflammation in Patients with Familial Mediterranean Fever Disease.
Kılıçaslan E; Düzenli T; Çelik S; Kaplan M; Öktenli Ç; Top C
Mediterr J Rheumatol; 2022 Sep; 33(3):322-327. PubMed ID: 36531416
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory bio- marker or familial Mediterranean fever disease.
Akyol T; Düzenli T; Tanoğlu A
Turk J Med Sci; 2021 Apr; 51(2):813-818. PubMed ID: 33306334
[TBL] [Abstract][Full Text] [Related]
7. Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever?
Oncu K; Yazgan Y; Tanoglu A; Kaplan M; Ermis F; Ipcioglu OM; Kara M; Kucuk I; Ozari HO
Dig Dis Sci; 2013 Nov; 58(11):3212-7. PubMed ID: 23925820
[TBL] [Abstract][Full Text] [Related]
8. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
[TBL] [Abstract][Full Text] [Related]
9. Interventions for reducing inflammation in familial Mediterranean fever.
Yin X; Tian F; Wu B; Xu T
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
[TBL] [Abstract][Full Text] [Related]
10. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
Sahin N; Ozdemir Cicek S; Pac Kisaarslan A; Poyrazoglu MH; Gunduz Z; Dusunsel R
Mod Rheumatol; 2022 Jan; 32(1):177-185. PubMed ID: 33775204
[TBL] [Abstract][Full Text] [Related]
11. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
Can Sandikci S; Omma A; Yucel C; Omma T
Clin Rheumatol; 2021 Feb; 40(2):669-674. PubMed ID: 32623649
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine immune system in familial Mediterranean fever.
Topaloğlu R; Bilginer Y; Alikaşifoğlu A; Ozaltin F; Beşbaş N; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2010; 52(6):588-93. PubMed ID: 21428190
[TBL] [Abstract][Full Text] [Related]
13. Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.
Tezcan D; Onmaz DE; Sivrikaya A; Hakbilen S; Körez MK; Gülcemal S; Yılmaz S
Ir J Med Sci; 2023 Aug; 192(4):2015-2022. PubMed ID: 36163581
[TBL] [Abstract][Full Text] [Related]
14. Exploring S100A8/A9, Neopterin, and MMP3 in Familial Mediterranean Fever.
Kilinc OC; Akdeniz YS; Taskin Z; Karabulut M; Kaya A; Bolayırlı IM; Can G; Ugurlu S
Clin Exp Immunol; 2024 Jun; ():. PubMed ID: 38864482
[TBL] [Abstract][Full Text] [Related]
15. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
Gucenmez OA; Kume T; Makay B; Babayigit O; Arslan N; Unsal E
Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
[TBL] [Abstract][Full Text] [Related]
17. Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study.
Deveci K; Gokakin AK; Boztosun A; Deveci H; Senel S; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):261-5. PubMed ID: 23377818
[TBL] [Abstract][Full Text] [Related]
18. Trace element levels in patients with familial mediterranean Fever.
Yildirim K; Uzkeser H; Uyanik A; Karatay S; Kiziltunc A
Eurasian J Med; 2011 Aug; 43(2):79-82. PubMed ID: 25610168
[TBL] [Abstract][Full Text] [Related]
19. The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis.
Kucuk A; Erol MF; Senel S; Eroler E; Yumun HA; Uslu AU; Erol AM; Tihan D; Duman U; Kucukkartallar T; Solak Y
Korean J Intern Med; 2016 Mar; 31(2):386-91. PubMed ID: 26864298
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.
Haznedaroglu S; Oztürk MA; Sancak B; Goker B; Onat AM; Bukan N; Ertenli I; Kiraz S; Calguneri M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S77-80. PubMed ID: 16273770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
